These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
638 related articles for article (PubMed ID: 19863443)
1. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443 [TBL] [Abstract][Full Text] [Related]
2. Adaptive immune responses against parvovirus B19 in patients with myocardial disease. Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860 [TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365 [TBL] [Abstract][Full Text] [Related]
4. Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy. Ruppert V; Meyer T; Balbach A; Richter A; Müller HH; Maisch B; Pankuweit S; J Med Virol; 2011 Oct; 83(10):1818-25. PubMed ID: 21837800 [TBL] [Abstract][Full Text] [Related]
5. No detection of human bocavirus in amniotic fluid samples from fetuses with hydrops or isolated effusions. Enders M; Lindner J; Wenzel JJ; Baisch C; Schalasta G; Enders G; Modrow S J Clin Virol; 2009 Aug; 45(4):300-3. PubMed ID: 19473872 [TBL] [Abstract][Full Text] [Related]
6. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. Lotze U; Egerer R; Glück B; Zell R; Sigusch H; Erhardt C; Heim A; Kandolf R; Bock T; Wutzler P; Figulla HR J Med Virol; 2010 Aug; 82(8):1449-57. PubMed ID: 20572082 [TBL] [Abstract][Full Text] [Related]
7. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. Corcioli F; Zakrzewska K; Rinieri A; Fanci R; Innocenti M; Civinini R; De Giorgi V; Di Lollo S; Azzi A J Med Virol; 2008 Nov; 80(11):2005-11. PubMed ID: 18814251 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical aspects of human bocavirus infection in children. Karalar L; Lindner J; Schimanski S; Kertai M; Segerer H; Modrow S Clin Microbiol Infect; 2010 Jun; 16(6):633-9. PubMed ID: 19681960 [TBL] [Abstract][Full Text] [Related]
9. Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients. Escher F; Kuhl U; Sabi T; Suckau L; Lassner D; Poller W; Schultheiss HP; Noutsias M Med Sci Monit; 2008 Jun; 14(6):CR333-338. PubMed ID: 18509278 [TBL] [Abstract][Full Text] [Related]
10. Absence of human bocavirus from deceased fetuses and their mothers. Riipinen A; Väisänen E; Lahtinen A; Karikoski R; Nuutila M; Surcel HM; Taskinen H; Hedman K; Söderlund-Venermo M J Clin Virol; 2010 Feb; 47(2):186-8. PubMed ID: 20031484 [TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987 [TBL] [Abstract][Full Text] [Related]
13. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors. Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India. Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946 [TBL] [Abstract][Full Text] [Related]
16. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. Cassinotti P; Siegl G; Michel BA; Brühlmann P J Med Virol; 1998 Nov; 56(3):199-204. PubMed ID: 9783685 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria. Opaleye OO; Fagbami AH; Lalremruata A; Kun JF J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387 [TBL] [Abstract][Full Text] [Related]
18. The detection of parvoviruses. Doyle S Methods Mol Biol; 2011; 665():213-31. PubMed ID: 21116804 [TBL] [Abstract][Full Text] [Related]
19. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia. Plentz A; Würdinger M; Kudlich M; Modrow S J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization. Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]